Tag: EQUATE
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment...
Itolizumab continues to demonstrate favorable safety and efficacy profile Rapid and durable responses resulted in clinically meaningful reduction in corticosteroid use ...